Avicenna Oncology
We are collaborating with Avicenna Oncology GmbH, a leading antibody drug conjugate development company based in Basel, Switzerland, to focus on the development of new PDCs by combining our patented phospholipid ether delivery platform with Avicenna's novel cytotoxic warheads (potent anti-cancer small molecules). Those novel cytotoxic warheads were previously attempted to be made as antibody drug conjugates and were unsuccessful.
MORE ABOUT OUR PARTNERSHIP WITH AVICENNA ONCOLOGY